|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000152556 |
Summary for PFKM |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000152556 | Gene symbol | PFKM |
| Gene name | phosphofructokinase, muscle | |
| HGNC | 8877 | |
| Entrez ID | 5213 | |
| Gene type | protein_coding | |
| Synonyms | PFKM|PFK-1|PPP1R122 | |
| UniProtAcc | P08237 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PFKM |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PFKM | 4.42e+03 | -1.00e+00 | 1.13e-01 | -8.86e+00 | 8.30e-19 | 3.76e-18 | KIRC |
| PFKM | 4.29e+03 | -2.28e+00 | 1.74e-01 | -1.32e+01 | 1.46e-39 | 3.16e-37 | HNSC |
| PFKM | 2.37e+03 | -1.07e+00 | 2.39e-01 | -4.49e+00 | 7.07e-06 | 4.35e-05 | BLCA |
| PFKM | 1.38e+03 | 1.51e+00 | 4.45e-01 | 3.39e+00 | 6.92e-04 | 2.44e-03 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for PFKM |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PFKM |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for PFKM |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BRCA | exon_skip_81749 | 8.14e-01 | 7.10e-01 | 2.39e+00 | 1.69e-02 | 4.90e-02 | 1.04e-01 |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| KICH | exon_skip_81749 | 8.00e-01 | 9.02e-01 | -2.33e+00 | 1.97e-02 | 2.96e-02 | -1.02e-01 |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| LUSC | exon_skip_81749 | 8.88e-01 | 7.62e-01 | 4.42e+00 | 1.00e-05 | 7.43e-05 | 1.26e-01 |
| READ | exon_skip_81749 | 6.78e-01 | 8.19e-01 | -2.21e+00 | 2.70e-02 | 3.69e-02 | -1.41e-01 |
Top |
RNA A-to-I editing events in TCGA for PFKM |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PFKM |
| TFs related to PFKM. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| MESO | ZNF79 | PFKM | 2.78e+00 | 6.33e-03 | 4.18e+00 | 9.82e-01 | Female-biased |
| PFKM related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PFKM |
| RBPs related to ES in PFKM. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | HNRNPH2 | exon_skip_81744 | 6.57e+00 | 9.81e-01 | 6.04e+00 | 2.16e-03 | Male-biased |
| STAD | RBM42 | exon_skip_81751 | 1.36e+01 | 9.99e-01 | 1.29e+01 | 1.10e-03 | Male-biased |
| STAD | SAMD4A | exon_skip_81755 | 6.78e+00 | 9.81e-01 | 6.32e+00 | 3.64e-03 | Male-biased |
| ACC | SAMD4A | exon_skip_81755 | 7.24e+00 | 9.82e-01 | 6.74e+00 | 5.78e-03 | Male-biased |
| UVM | HNRNPH2 | exon_skip_81744 | 6.31e+00 | 3.14e-03 | 6.71e+00 | 9.81e-01 | Female-biased |
| THYM | HNRNPH2 | exon_skip_81744 | 6.69e+00 | 9.84e-01 | 5.91e+00 | 8.55e-05 | Male-biased |
| THYM | RBM42 | exon_skip_81751 | 1.37e+01 | 9.96e-01 | 1.33e+01 | 3.60e-03 | Male-biased |
| LUSC | SAMD4A | exon_skip_81755 | 6.90e+00 | 9.81e-01 | 6.42e+00 | 3.87e-03 | Male-biased |
| DLBC | RBM42 | exon_skip_81751 | 1.39e+01 | 9.97e-01 | 1.35e+01 | 3.20e-03 | Male-biased |
| LUAD | RBM42 | exon_skip_81751 | 1.30e+01 | 7.06e-04 | 1.36e+01 | 9.99e-01 | Female-biased |
| BRCA | SAMD4A | exon_skip_81755 | 6.62e+00 | 1.53e-03 | 7.87e+00 | 9.89e-01 | Female-biased |
| ESCA | RBM42 | exon_skip_81751 | 1.28e+01 | 8.28e-03 | 1.33e+01 | 9.91e-01 | Female-biased |
| THCA | HNRNPH2 | exon_skip_81744 | 6.28e+00 | 6.20e-04 | 6.83e+00 | 9.84e-01 | Female-biased |
| PCPG | KHDRBS3 | exon_skip_81755 | 8.64e+00 | 1.27e-02 | 8.94e+00 | 9.83e-01 | Female-biased |
| LGG | RBM42 | exon_skip_81751 | 1.28e+01 | 1.88e-02 | 1.31e+01 | 9.81e-01 | Female-biased |
| PAAD | DAZAP1 | exon_skip_81747 | 1.21e+01 | 9.99e-01 | 1.16e+01 | 8.39e-04 | Male-biased |
| PAAD | HNRNPA1L2 | exon_skip_81747 | 9.95e+00 | 9.95e-01 | 9.56e+00 | 3.03e-03 | Male-biased |
| PAAD | RBM42 | exon_skip_81751 | 1.34e+01 | 9.93e-01 | 1.31e+01 | 6.28e-03 | Male-biased |
| KIRC | SAMD4A | exon_skip_81755 | 7.08e+00 | 9.87e-01 | 6.54e+00 | 6.34e-04 | Male-biased |
| KICH | FXR2 | exon_skip_81744 | 7.40e+00 | 1.02e-02 | 7.72e+00 | 9.80e-01 | Female-biased |
| KICH | RBM42 | exon_skip_81751 | 1.35e+01 | 9.99e-01 | 1.28e+01 | 3.36e-04 | Male-biased |
| BLCA | RBM42 | exon_skip_81751 | 1.32e+01 | 1.37e-03 | 1.38e+01 | 9.98e-01 | Female-biased |
| HNSC | RBM42 | exon_skip_81751 | 1.31e+01 | 1.50e-03 | 1.36e+01 | 9.98e-01 | Female-biased |
| PFKM related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000152556 | AC011632.1,hsa-mir-142,PFKM | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000152556 | DUBR,hsa-mir-142,PFKM | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000152556 | NNT-AS1,hsa-mir-142,PFKM | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000152556 | AL161757.4,hsa-mir-142,PFKM | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000152556 | MAGI2-AS3,hsa-mir-142,PFKM | Male-specific ceRNA | TCGA-HNSC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73104190 | chr12:47716040:G:A | - | 0.104515159092374 | 0.0477451768512301 | LUSC | Female-baised eQTL |
| rs73104197 | chr12:47717273:T:G | - | 0.104515159092374 | 0.0477451768512301 | LUSC | Female-baised eQTL |
| rs12228838 | chr12:52860733:A:G | - | 0.0968100799154744 | 0.0407070416600777 | KIRC | Female-baised eQTL |
| rs78319805 | chr12:40841790:G:A | - | 0.0886068289197263 | 0.0160382550211489 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11181634 | chr12:42675501:G:T | - | 0.0796211474526039 | 0.0150668012391623 | KIRC | Male-baised eQTL |
| rs2730903 | chr12:38606153:T:C | - | -0.0606566807763168 | 0.0360974091098556 | BLCA | Male-baised eQTL |
| rs12297619 | chr12:38576289:T:C | - | -0.0593783461034023 | 0.046779189251922 | BLCA | Male-baised eQTL |
| rs2653726 | chr12:38577704:C:T | - | -0.0593783461034023 | 0.046779189251922 | BLCA | Male-baised eQTL |
| rs2730911 | chr12:38594048:T:C | - | -0.0593783461034023 | 0.046779189251922 | BLCA | Male-baised eQTL |
| rs10491995 | chr12:41860571:C:G | - | 0.104630204309423 | 0.00232563830396023 | LUAD | Male-baised eQTL |
| rs7953773 | chr12:42889633:A:C | - | 0.100300465520844 | 0.00806406295019081 | LUAD | Male-baised eQTL |
| rs11181204 | chr12:41864612:G:A | - | 0.092204731216576 | 0.01461346480351 | LUAD | Male-baised eQTL |
| rs11532503 | chr12:41872732:A:G | - | 0.092204731216576 | 0.01461346480351 | LUAD | Male-baised eQTL |
| rs11536158 | chr12:41872996:G:A | - | 0.092204731216576 | 0.01461346480351 | LUAD | Male-baised eQTL |
| rs60743130 | chr12:41873780:T:C | - | 0.092204731216576 | 0.01461346480351 | LUAD | Male-baised eQTL |
| rs12581985 | chr12:41877133:A:C | - | 0.092204731216576 | 0.01461346480351 | LUAD | Male-baised eQTL |
| rs11181215 | chr12:41879395:A:G | - | 0.092204731216576 | 0.01461346480351 | LUAD | Male-baised eQTL |
| rs11181224 | chr12:41889540:C:T | - | 0.0990274865899719 | 0.0146270049714605 | LUAD | Male-baised eQTL |
| rs11831722 | chr12:42886064:A:G | - | 0.0858299123110259 | 0.0322402997739848 | LUAD | Male-baised eQTL |
| rs11835318 | chr12:42888814:G:A | - | 0.0856283601041523 | 0.0332946099874603 | LUAD | Male-baised eQTL |
| rs4344537 | chr12:48498668:T:C | - | 0.0747637619482257 | 0.0366156164770909 | LUAD | Male-baised eQTL |
| rs12316395 | chr12:43563846:A:C | - | -0.0575464500846171 | 0.0250773495126132 | COAD | Male-baised eQTL |
| rs10880528 | chr12:43565685:G:T | - | -0.0575464500846171 | 0.0250773495126132 | COAD | Male-baised eQTL |
| rs7358551 | chr12:43563959:G:A | - | -0.0570051973660902 | 0.0292252972980795 | COAD | Male-baised eQTL |
| rs7358701 | chr12:43564790:A:G | - | -0.0560870994392867 | 0.0351059896469329 | COAD | Male-baised eQTL |
| rs58826621 | chr12:51735879:A:G | - | 0.112217633340228 | 0.0375905586134868 | COAD | Male-baised eQTL |
| rs58595992 | chr12:51730007:A:G | - | 0.113052529449639 | 0.0398390461560388 | COAD | Male-baised eQTL |
| rs57792817 | chr12:51734320:A:G | - | 0.113052529449639 | 0.0398390461560388 | COAD | Male-baised eQTL |
| rs7959233 | chr12:51742247:A:G | - | 0.113052529449639 | 0.0398390461560388 | COAD | Male-baised eQTL |
| rs34621434 | chr12:51743789:G:T | - | 0.113052529449639 | 0.0398390461560388 | COAD | Male-baised eQTL |
| rs11169692 | chr12:51064782:G:A | - | 0.065219432777664 | 0.0447275890669528 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs3741632 | chr12:48693180:G:A | Distant downstream | -0.0362846303312141 | 0.0382568557112675 | LUAD | Female-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs2705130 | chr12:48494191:T:C | Distant downstream | 0.0198854643864924 | 0.0394549105497484 | THCA | Female-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs2731108 | chr12:48493578:G:A | Distant downstream | 0.019624241295777 | 0.0429165739869417 | THCA | Female-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs2731099 | chr12:48490143:C:T | Distant downstream | 0.0192868307737703 | 0.0468702044846351 | THCA | Female-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs2731100 | chr12:48490375:G:C | Distant downstream | 0.0192868307737703 | 0.0468702044846351 | THCA | Female-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs2731103 | chr12:48490973:C:A | Distant downstream | 0.0192868307737703 | 0.0468702044846351 | THCA | Female-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs2731106 | chr12:48492701:C:T | Distant downstream | 0.0192868307737703 | 0.0468702044846351 | THCA | Female-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs10875713 | chr12:47970680:A:T | Distant upstream | 0.12515529040109 | 0.0274336449657384 | KIRP | Female-baised sQTL |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs12827401 | chr12:47916072:A:T | Distant upstream | 0.0354717999210424 | 0.0211855810238606 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs35609792 | chr12:47916189:G:A | Distant upstream | 0.0354717999210424 | 0.0211855810238606 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs11568820 | chr12:47908762:C:T | Distant upstream | 0.0372239672734169 | 0.0221608446595275 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs7976091 | chr12:47910769:C:T | Distant upstream | 0.0371661608590664 | 0.0230467665600169 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs12304110 | chr12:47914100:A:G | Distant upstream | 0.0344520982713007 | 0.0290463184060282 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs11168311 | chr12:47934726:C:A | Distant upstream | 0.043820202026122 | 0.033613565590347 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs2130095 | chr12:48244972:G:A | Distant downstream | 0.0343148022138992 | 0.0354286468089 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs11168308 | chr12:47926137:G:T | Distant upstream | 0.0360585798253535 | 0.037924237666831 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs10783243 | chr12:48259220:G:A | Distant downstream | 0.0339108968068028 | 0.0388021244008192 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs9645811 | chr12:48285453:A:G | Distant downstream | 0.0336199447608081 | 0.0424137957409202 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs7303966 | chr12:47926326:C:T | Distant upstream | 0.037458780739474 | 0.0429453843559574 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs7315992 | chr12:47925542:T:C | Distant upstream | 0.0370702563828703 | 0.0471272933464453 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs7300301 | chr12:47925800:G:A | Distant upstream | 0.0370702563828703 | 0.0471272933464453 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs7300088 | chr12:47925811:A:G | Distant upstream | 0.0370702563828703 | 0.0471272933464453 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs10875703 | chr12:47925919:A:T | Distant upstream | 0.0370702563828703 | 0.0471272933464453 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs12316950 | chr12:47926077:A:G | Distant upstream | 0.0370702563828703 | 0.0471272933464453 | KIRC | Male-baised sQTL |
| exon_skip_81749 | chr12:48135290:48135383 | In-frame | rs11168318 | chr12:47938746:G:A | Distant upstream | 0.0418774206365897 | 0.0486631537016387 | KIRC | Male-baised sQTL |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PFKM |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000152556 | PFKM | C0002152 | Alloxan Diabetes | 1 | CTD_human |
| ENSG00000152556 | PFKM | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
| ENSG00000152556 | PFKM | C0017926 | Glycogen Storage Disease Type VII | 2 | CTD_human |
| ENSG00000152556 | PFKM | C0038433 | Streptozotocin Diabetes | 1 | CTD_human |
| ENSG00000152556 | PFKM | C0151744 | Myocardial Ischemia | 1 | CTD_human |
